Chemed Corp

NYSE:CHEHealthcareNASDAQ:NQUSSGSTOXX:EDD24BP

$516.07+1.53%At closeAt close · Wed 21 Oct · ≈ AED 1,895.27 · Market cap $6.75B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	33.7%	36.0%	35.8%	35.3%	35.1%	30.0%	—	—
Operating margin	18.7%	16.0%	16.1%	15.0%	15.1%	13.4%	13.4%	+0.0 pts
Net margin	15.4%	12.6%	11.7%	12.0%	12.4%	10.5%	10.5%	+0.0 pts
EBITDA margin	21.9%	19.2%	18.4%	18.3%	19.1%	16.7%	—	—
Return on equity	35.4%	43.1%	31.3%	24.6%	27.0%	27.1%	27.1%	+0.0 pts
Return on assets	22.3%	20.0%	17.3%	16.3%	18.1%	16.2%	16.2%	+0.0 pts
Return on capital employed	34.3%	33.0%	30.0%	25.1%	26.5%	25.0%	—	—
Debt / equity	0.2×	0.5×	0.3×	0.1×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	9.4%	24.1%	17.1%	9.3%	8.4%	9.4%	—	—
Interest coverage	165.5×	183.6×	74.9×	109.6×	205.9×	193.3×	—	—
Current ratio	1.1×	0.8×	0.9×	1.6×	1.4×	1.1×	1.1×	+0.0%
Quick ratio	1.1×	0.7×	0.9×	1.6×	1.4×	1.0×	—	—
Cash ratio	0.5×	0.1×	0.2×	0.8×	0.6×	0.3×	0.3×	+0.0%
Asset turnover	1.4×	1.6×	1.5×	1.4×	1.5×	1.5×	—	—
Inventory turnover	194.2×	135.5×	133.4×	122.1×	192.5×	234.9×	—	—
Receivables turnover	16.4×	15.6×	15.3×	12.5×	14.2×	13.9×	—	—
Dividend payout	6.6%	8.2%	8.8%	8.6%	9.0%	11.9%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.